Australia - English - Department of Health (Therapeutic Goods Administration)

lupin australia pty limited - levetiracetam, quantity: 250 mg - tablet, film coated - excipient ingredients: maize starch; colloidal anhydrous silica; croscarmellose sodium; povidone; microcrystalline cellulose; purified talc; magnesium stearate; titanium dioxide; macrogol 6000; polyvinyl alcohol; macrogol 3350; indigo carmine aluminium lake - use in epileptic patients aged 4 years and older, initially as add-on therapy, in the treatment of partial onset seizures with or without secondary generalisation. monotherapy in the treatment of partial onset seizures, with or without secondary generalisation, in patients from 16 years of age with newly diagnosed epilepsy. add-on therapy in the treatment of myoclonic seizures in adults and adolescents from 12 years of age with juvenile myoclonic epilepsy (jme). add-on therapy in the treatment of primary generalized tonic clonic (pgtc) seizures in adults and children from 4 years of age with idiopathic generalised epilepsy (ige).

Ireland - English - HPRA (Health Products Regulatory Authority)

boehringer ingelheim vetmedica gmbh - bromhexine hydrochloride - oral powder - 10 milligram(s)/gram - bromhexine

Ireland - English - HPRA (Health Products Regulatory Authority)

boehringer ingelheim vetmedica gmbh - dembrexine hydrochloride monohydrate - oral powder - 5 milligram(s)/gram - dembrexine hydrochloride

Ireland - English - HPRA (Health Products Regulatory Authority)

dechra regulatory b.v. - phenylbutazone - oral powder - 1.0 gram(s) - phenylbutazone

Ireland - English - HPRA (Health Products Regulatory Authority)

pharmanovo veterinärarzneimittel gmbh - bromhexine hydrochloride - oral powder - 25 milligram(s)/gram - bromhexine

Canada - English - Health Canada

mantra pharma inc - levetiracetam - tablet - 250mg - levetiracetam 250mg

Canada - English - Health Canada

mantra pharma inc - levetiracetam - tablet - 500mg - levetiracetam 500mg

Canada - English - Health Canada

mantra pharma inc - levetiracetam - tablet - 750mg - levetiracetam 750mg

Canada - English - Health Canada

sanis health inc - levetiracetam - tablet - 1000mg - levetiracetam 1000mg

New Zealand - English - Medsafe (Medicines Safety Authority)

aft pharmaceuticals ltd - levetiracetam 100 mg/ml;   - oral solution - 100 mg/ml - active: levetiracetam 100 mg/ml   excipient: acesulfame potassium ammonium glycyrrhizinate citric acid monohydrate glycerol grape flavour maltitol methyl hydroxybenzoate propyl hydroxybenzoate sodium citrate - use in epileptic patients aged 4 years and older, initially as add on therapy, in the treatment of partial onset seizures with or without secondary generalisation. monotherapy in the treatment of partial onset seizures, with or without secondary generalisation, in patients from 16 years of age with newly diagnosed epilepsy. add on therapy in the treatment of myoclonic seizures in adults and adolescents from 12 years of age with juvenile myoclonic epilepsy (jme). add on therapy in the treatment of primary generalized tonic-clonic seizures in adults and children from 4 years of age with idiopathic generalized epilepsy (ige).